| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/08/2006 | US7087721 Compositions, kits and treating methods for alteration cell-cell adhesion, transport, or permeation properties of tissues |
| 08/08/2006 | US7087718 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 08/08/2006 | US7087709 Nitrosation of a organosulfur polymer; coating medical equipment such as tubes, catheters |
| 08/08/2006 | US7087700 Trialkalnolamines that have been esterified with organic acids including long chain fatty acids and reacted with diisocyanates |
| 08/08/2006 | US7087661 Safe and effective biofilm inhibitory compounds and health-related uses thereof |
| 08/08/2006 | US7087649 Alcoholism; gastrointestinal disorders, Crohn's disease, antiulcer agents induced by alcoholism |
| 08/08/2006 | US7087648 Methods for modulating macrophage proliferation using polyamine analogs |
| 08/08/2006 | US7087647 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| 08/08/2006 | US7087646 Composition for external application |
| 08/08/2006 | US7087645 such as 4-[4-[[1-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]thio]-1-methylethyl]thio]-2,6-bis(1,1-dimethylethyl)phenoxy]butyric acid; side effect reduction |
| 08/08/2006 | US7087644 Cardiovascular disorders; stimulant of guanylate cyclase ; therapy for liver fibrosis |
| 08/08/2006 | US7087643 Side effect reduction of diabetes, strokes, multiple sclerosis |
| 08/08/2006 | US7087642 Inhibitors of IMPDH enzyme |
| 08/08/2006 | US7087641 4β-1″-[(2″-substituted benzoyl) anilino]podophyllotoxin analogues useful as anticancer agents |
| 08/08/2006 | US7087640 Substance with sedative effect |
| 08/08/2006 | US7087639 Organoselenium compounds for cancer chemoprevention |
| 08/08/2006 | US7087637 Substituted indoles which are PARP inhibitors |
| 08/08/2006 | US7087636 A 4,7-methano-1,2-benzisothiazol-3-one-1,1-dioxide derivatives, for treating cancer, immune modulation |
| 08/08/2006 | US7087635 3-substituted oxindole β3 agonists |
| 08/08/2006 | US7087634 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/08/2006 | US7087633 Method for treating perinatal asphyxia in a human or animal neonate |
| 08/08/2006 | US7087632 Inhibition of the interaction of RAGE with its ligands; treatment acute and chronic inflammation, the development of diabetic late complications, Alzheimer's disease, erectile dysfunction, and tumor invasion and metastasis. |
| 08/08/2006 | US7087631 Aryltetrazole compounds, and compositions thereof |
| 08/08/2006 | US7087630 Cyclooxygenase 2 selective inhibitors, compositions and methods of use |
| 08/08/2006 | US7087629 Useful activity against Gram-positive pathogens and, in particular, against various strains exhibiting resistance to vancomycin and against E. faecium strains resistant to both aminoglycosides and clinically used beta-lactams |
| 08/08/2006 | US7087628 Heteroaryl and heterocyclic nitrogen ring containing hydrazide compounds useful for treating neurodegenerative disorderes |
| 08/08/2006 | US7087627 Synergistic mixture of vasculation damaging agent such as tubulin binding agent and inhibitor of forming of nitric oxide; antitumor agents; anticancer agents |
| 08/08/2006 | US7087626 TGF-beta signal transduction inhibitors |
| 08/08/2006 | US7087625 N-substituted aniline and diphenylamine analogs |
| 08/08/2006 | US7087624 Substituted pyrazole compounds |
| 08/08/2006 | US7087623 Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof |
| 08/08/2006 | US7087622 Pyridone compounds as inhibitors of bacterial type III protein secreation systems |
| 08/08/2006 | US7087621 Benzo- and azabenzodithiazole compounds |
| 08/08/2006 | US7087620 Cardiovascular disorders; contorlling artrial fibrillation |
| 08/08/2006 | US7087619 Method for the treatment of urinary incontinence |
| 08/08/2006 | US7087618 Pyrazolopyridinyl pyrimidine therapeutic compounds |
| 08/08/2006 | US7087617 Psychological disorders; anxiolytic agents; central nervous system disorders; antidepressants |
| 08/08/2006 | US7087615 Antiinflammatory agents; antiarthritic agents |
| 08/08/2006 | US7087614 Pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 08/08/2006 | US7087613 Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride |
| 08/08/2006 | US7087612 Amine oxidase inhibitor; therapy for Alzheimer's diseases, Parkinson's disease |
| 08/08/2006 | US7087611 Reacting ziprasidone with hydrochloric acid in solvent; salt formation; drying |
| 08/08/2006 | US7087610 Aids therapy |
| 08/08/2006 | US7087609 3-phenyl-N-{1-[3-(4-pyridin-2-yl-piperazin-1-yl)-phenyl]-ethyl}-acrylamide for example; migraine, neuropathic pain, convulsions, mania, epilepsy, anxiety, depression, bipolar disorder, and neurodegenerative disorders |
| 08/08/2006 | US7087608 Use of PDGF receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy |
| 08/08/2006 | US7087607 Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines |
| 08/08/2006 | US7087606 Water-soluble phenylpyridazine compounds and compositions containing the same |
| 08/08/2006 | US7087605 5-Ethyl-imidazotriazinones |
| 08/08/2006 | US7087604 Antiarthritic agents;multiple sclerosis; anticholesterol agents; cardiovascular disorders |
| 08/08/2006 | US7087603 Pyrazole compounds useful as protein kinase inhibitors |
| 08/08/2006 | US7087602 Cinnoline derivatives and use as medicine |
| 08/08/2006 | US7087601 Psychological disorders; anxiolytic agents; antidepressants; analgesics ; schizophrenia |
| 08/08/2006 | US7087600 Anticancer agents; side effect reduction |
| 08/08/2006 | US7087599 Estrogen receptor modulators |
| 08/08/2006 | US7087598 Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring |
| 08/08/2006 | US7087597 Pyrimidine 5-carboxamide compounds, process for producing the same and use thereof |
| 08/08/2006 | US7087596 2-oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivatives for the treatment of epilepsy and other neurological disorders |
| 08/08/2006 | US7087595 Antihistaminic spiro compounds |
| 08/08/2006 | US7087594 Alkyl ether derivatives or salts thereof |
| 08/08/2006 | US7087593 Psychological disorder treatments that increase the activity of cholinergic receptors |
| 08/08/2006 | US7087592 Compositions comprising purified 2-methoxyestradiol and methods of producing same |
| 08/08/2006 | US7087591 21-substituted progesterone derivatives as new antiprogestational agents |
| 08/08/2006 | US7087590 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them |
| 08/08/2006 | US7087589 Chemically modified adenine or uracil bounded to a cyclopentyl group derivatized with a cyclopropane bridge, and such compound binds a receptor |
| 08/08/2006 | US7087588 to gastrointestal systems, kidneys |
| 08/08/2006 | US7087587 Blending with adjuvants, compression, coating |
| 08/08/2006 | US7087586 Oligonucleotide compositions and their use to induce differentiation of cells |
| 08/08/2006 | US7087585 Tripeptide of FcγRIIA |
| 08/08/2006 | US7087583 Detecting antitumor protein in sample; obtain protein sample, incubate with preferential nucleotide sequence, detect bound nucleotide sequences, bound sequences indicate presence of antitumor protein |
| 08/08/2006 | US7087582 Cyclin-dependent kinase inhibitor; mixture with immunotherapy drug, cytokine and prodrug enzyme |
| 08/08/2006 | US7087581 Regeneration of sensitive cells with cell proliferative agents; cyclin-dependent kinase inhibitor; administering antibody |
| 08/08/2006 | US7087579 Human sodium glucose co-transporter 2 (SGLT2) inhibitors; hypoglycemic agents, antidiabetic agents; obesity; prodrugs |
| 08/08/2006 | US7087575 Treating the effect of nicotine |
| 08/08/2006 | US7087424 In animal or plants; administering an sugar acid such as galactonic acid, gluconic acid, galacturonic acid |
| 08/08/2006 | US7087413 Hyaluronan synthase gene and uses thereof |
| 08/08/2006 | US7087400 Using a 11 beta-reductase inhibitor in the manufacture of a medicament for control of 11-keto steroid conversion to 11 beta-hydroxysteroid in vivo |
| 08/08/2006 | US7087259 Can be used for the production of beverages having, despite a high polyphenol content, a low degree of bitterness acceptable to the consumer |
| 08/08/2006 | US7087252 For therapy of senile dementia, and inhibition of aggregation of blood platelets |
| 08/08/2006 | US7087249 Nanocrystalline antimicrobial metals (noble metals)formed with atomic disorder are capable of releasing highly active clusters of the antimicrobial metal sufficient to cause microbiocidal effect; anti-inflammatory activity |
| 08/08/2006 | US7087244 Thermogelling oligopeptide polymers |
| 08/08/2006 | US7087241 Administering a transmucosal formulation, comprising oxybutynin to a subject to provide a plasma area under the curve (AUC) ratio of oxybutynin to an oxybutynin metabolite of from about 0.5:1 to about 5:1, wherein the transmucosal formulation optionally includes a permeation enhancer |
| 08/08/2006 | US7087238 Skin disorders; wrinkle resistance; containing ubiquinone |
| 08/08/2006 | US7087237 Ocular solutions |
| 08/08/2006 | US7087229 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 08/08/2006 | US7087223 Preventives and/or remedies for hyperphosphatemia |
| 08/08/2006 | US7087222 Introducing an ophthalmically compatible form of a retinoid into the eye of the patient in an amount sufficient to enhance the integrity of the corneal epithelium |
| 08/08/2006 | US7087218 Delivery of diazepam through an inhalation route |
| 08/08/2006 | US7087217 Condensation aerosol for delivery of a drug selected from the group consisting of indomethacin, ketoprofen, celcoxib, rofecoxib, meclofenamic acid, fenoprofen, diflunisal, tolfenamic acid, naproxen, ibuprofen, flurbiprofen and nabumetone |
| 08/08/2006 | US7087216 Condensation aerosol for delivery of a drug selected from the group consisting of zaleplon, zolpidem and zopiclone |
| 08/08/2006 | US7087215 Methods of administering and enhancing absorption of pharmaceutical agents |
| 08/08/2006 | US7087214 Water-soluble porphyrin platinum compounds of the tetraarylporphyrin platinum derivatives type or of the hematoporphyrin platinum derivatives type with high tumor selectivity and their use for the treatment of benign and |
| 08/08/2006 | US7087212 Multilayer binding; lamellar surface structure |
| 08/08/2006 | US7086532 Titration/compliance pack with increasing doses |
| 08/08/2006 | CA2582255A1 4-phenylbutyric acid controlled-release formulations for therapeutic use |
| 08/08/2006 | CA2394902C Effervescent histamine h2 antagonist composition |
| 08/08/2006 | CA2358938C Methods for assessing, improving, or maintaining urogenital health in postmenopausal women |
| 08/08/2006 | CA2356985C 5ht1 antagonists for antidepressant therapy |
| 08/08/2006 | CA2348016C Controlled release liquid delivery compositions with low initial drug burst |
| 08/08/2006 | CA2282183C Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines |
| 08/08/2006 | CA2268321C Use of metal complexes to treat gastrointestinal infections |